INGREDION INC
INGRNYSE🏆 #1033 by market capEarnings Nov 3US Equity
$103.46▼ $1.20 (−1.16%)
Live1h▼ 0.5%
24h▼ 1.2%
7d▲ 0.2%
14d▲ 1.7%
30d▲ 4.1%
1y▼ 18.4%
🏦Market Cap
$6.52B
Small Cap
📈Revenue Growth (YoY)
-1.4%
Declining
📊Gross Margin
23.7%
Moderate
💵FCF Margin
7.3%
Moderate
⚖️P/S Ratio
0.9x
Cheap
Otter Score
41
Weak
📊
Analyst Ratings
Price
$103.46
Total
21
Raised
2
Lowered
6
Avg PT
$116.00
H / L
$118 / $114
| Institution | Action | Rating | Date |
|---|---|---|---|
Barclays | Reiterated | Equal Weight | 2026-08-05 |
UBS | Reiterated | Neutral | 2026-08-05 |
Oppenheimer | Downgraded | Outperform → Perform | 2026-06-09 |
Stephens & Co. | Reiterated | Equal Weight | 2026-02-04 |
BMO Capital | Reiterated | Market Perform | 2025-11-05 |
Goldman Sachs | Reiterated | Buy | 2024-02-16 |
Credit Suisse | Reiterated | Neutral | 2023-02-09 |
Berenberg | Reiterated | Buy | 2020-07-16 |
Citigroup | Reiterated | Neutral | 2019-08-06 |
Vertical Research | Downgraded | Buy → Hold | 2019-01-24 |
Vertical Group | Downgraded | Buy → Hold | 2019-01-24 |
Jefferies | Reiterated | Buy | 2016-11-30 |
Tigress Financial | Reiterated | Underperform | 2015-12-23 |
Canaccord Genuity | Reiterated | Buy | 2015-06-25 |
Standpoint Research | Downgraded | Buy → Hold | 2014-11-18 |
Standpoint | Upgraded | Hold → Buy | 2014-10-14 |
BB&T Capital | Downgraded | Buy → Hold | 2014-06-18 |
Keybanc | Reiterated | Buy | 2014-06-17 |
KeyBanc | Reiterated | Buy | 2014-06-17 |
Davenport | Upgraded | Neutral → Buy | 2013-08-01 |
Gabelli & Co. | Downgraded | Buy → Hold | 2013-07-16 |
One row per institution, most recent rating